Annual Retained Earnings
-$154.46 M
-$64.73 M-72.15%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual retained earnings is -$154.46 million, with the most recent change of -$64.73 million (-72.15%) on December 31, 2023.
- During the last 3 years, ANTX annual retained earnings has fallen by -$134.14 million (-660.15%).
- ANTX annual retained earnings is now -660.15% below its all-time high of -$20.32 million, reached on December 31, 2020.
Performance
ANTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$198.25 M
-$12.75 M-6.87%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly retained earnings is -$198.25 million, with the most recent change of -$12.75 million (-6.87%) on September 30, 2024.
- Over the past year, ANTX quarterly retained earnings has dropped by -$27.18 million (-15.89%).
- ANTX quarterly retained earnings is now -318.40% below its all-time high of -$47.38 million, reached on December 1, 2021.
Performance
ANTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ANTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.2% | -15.9% |
| 3 y3 years | -660.1% | -15.9% |
| 5 y5 years | -660.1% | -15.9% |
ANTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -226.0% | at low | -318.4% | at low |
| 5 y | 5-year | -660.1% | at low | -318.4% | at low |
| alltime | all time | -660.1% | at low | -318.4% | at low |
AN2 Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$198.25 M(+6.9%) |
| Jun 2024 | - | -$185.51 M(+8.4%) |
| Mar 2024 | - | -$171.07 M(+10.8%) |
| Dec 2023 | -$154.46 M(+72.1%) | -$154.46 M(+12.3%) |
| Sep 2023 | - | -$137.56 M(+13.8%) |
| Jun 2023 | - | -$120.85 M(+15.0%) |
| Mar 2023 | - | -$105.05 M(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$89.72 M(+89.4%) | -$89.72 M(+15.2%) |
| Sep 2022 | - | -$77.88 M(+17.0%) |
| Jun 2022 | - | -$66.54 M(+17.9%) |
| Mar 2022 | - | -$56.42 M(+19.1%) |
| Dec 2021 | -$47.38 M(+133.2%) | - |
| Dec 2021 | - | -$47.38 M |
| Dec 2020 | -$20.32 M | - |
FAQ
- What is AN2 Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for AN2 Therapeutics?
- What is AN2 Therapeutics annual retained earnings year-on-year change?
- What is AN2 Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly retained earnings year-on-year change?
What is AN2 Therapeutics annual retained earnings?
The current annual retained earnings of ANTX is -$154.46 M
What is the all time high annual retained earnings for AN2 Therapeutics?
AN2 Therapeutics all-time high annual retained earnings is -$20.32 M
What is AN2 Therapeutics annual retained earnings year-on-year change?
Over the past year, ANTX annual retained earnings has changed by -$64.73 M (-72.15%)
What is AN2 Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ANTX is -$198.25 M
What is the all time high quarterly retained earnings for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly retained earnings is -$47.38 M
What is AN2 Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ANTX quarterly retained earnings has changed by -$27.18 M (-15.89%)